Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $28.41 USD
Change Today -0.20 / -0.70%
Volume 281.3K
MDCO On Other Exchanges
Symbol
Exchange
NASDAQ GS
As of 12:29 PM 07/1/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven R. Steinhubl M.D., FACC

Former Global Vice President of Thrombosis, The Medicines Company
AgeTotal Calculated CompensationThis person is connected to 3 board members in 1 different organizations across 3 different industries.

See Board Relationships
56--

Background*

Dr. Steven R. Steinhubl, M.D., FACC was Global Vice President of Thrombosis of Medicines Co. since February 2008. Dr. Steinhubl is responsible for the development programs for both cangrelor, an investigational antiplatelet agent, and Angiox(R) (bivalirudin) from the European headquarters in Zurich, Switzerland. Dr. Steinhubl joined Medicines Co. as Global Vice President, of Thrombosis. Dr. Steinhubl is a director of digital medicine at the Scripps Translational Science ...

Read Full Background

Corporate Headquarters*

8 Sylvan Way
Parsippany, New Jersey 07054

United States

Phone: 973-290-6000
Fax: 973-656-9898

Board Members Memberships*

2014-Present
Chairman

Education*

BS
Purdue University
MS
Georgetown University
Unknown/Other Education 1988
St Louis University School Of Medicine

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MDCO:US $28.41 USD -0.20

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Peter J. Arduini Chief Executive Officer, President, Director and Member of Special Award Committee
Integra LifeSciences Holdings Corporation
$827.8K
Dame Pamela Louise Makin MA, Ph.D.(Cantab), MBA, DBEChief Executive Officer and Executive Director
BTG plc
1.1M GBP
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
$552.5K
Erik Bogsch Chief Executive Officer, Managing Director, Member of Executive Board and Director
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt.
--
Joze Colaric President of Management Board and Chief Executive Officer
KrKa dd Novo Mesto
€758.0K
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MEDICINES COMPANY, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.